Intercept Pharmaceuticals | ICPT - Action



Action Changement Date
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amarin USD 184.7M 13.46M 2025-09
Amgen USD 6.22B 121M 2025-12
Arrowhead Research USD -173.08M 173.08M 2024-12
AstraZeneca USD 6.59B 126M 2025-09
Biogen USD 2.17B 41.3M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
GlaxoSmithKline GBP 6.12B 46M 2025-09
Incyte USD 101.06M 17.61M 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Moderna USD 332M 92M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
Novartis USD 6.42B 114M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12